D. Western Therapeutics Institute
4576
Needs Well
3992
Daiwa Cycle
5888
Osaka Yuka Industry
4124
Liberta
4935
(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 1,752.75%1.76B | -32.81%288.77M | -45.18%896.36M | -49.51%239.07M | 1.47%132.46M | 21.02%95.07M | -54.88%429.76M | 226.38%1.64B | -4.38%473.54M | 130.55M |
Cost of revenue | 917.08%1.7B | -31.32%252.34M | -35.69%1.13B | -38.57%416.38M | 17.63%180.86M | 52.74%166.88M | -55.12%367.4M | 251.53%1.76B | 69.35%677.76M | 153.76M |
Gross profit | 189.23%64.08M | -41.59%36.43M | -89.32%-235.16M | 13.18%-177.3M | -108.50%-48.4M | -133.87%-71.81M | -53.44%62.36M | -24,312.87%-124.21M | -315.00%-204.22M | -23.22M |
Operating expense | 9.69%495.69M | 50.50%631.13M | -11.71%1.84B | -26.09%495.52M | 8.75%469.27M | 2.12%451.9M | -21.62%419.35M | 74.82%2.08B | 37.27%670.46M | 431.53M |
Operating profit | 17.59%-431.62M | -66.59%-594.71M | 6.01%-2.07B | 23.08%-672.82M | -13.84%-517.67M | -10.67%-523.71M | 10.99%-356.99M | -85.34%-2.2B | -122.31%-874.68M | -454.74M |
Net non-operating interest income (expenses) | -197.77%-6M | 96.68%-4.04M | -12,185.61%-188.71M | -3,513.36%-63.27M | -3,119.70%-1.99M | -1,438.93%-2.02M | -43,467.14%-121.43M | 97.70%-1.54M | -254.45%-1.75M | 66K |
Non-operating interest income | -65.48%29K | 22.09%105K | -53.06%337K | -1,631.67%-919K | 574.53%1.09M | -60.93%84K | -69.50%86K | 138.54%718K | 566.67%60K | --161K |
Non-operating interest expense | 187.24%6.03M | 70.66%4.14M | 304.26%9.11M | -16.84%1.51M | 3,141.05%3.08M | 506.94%2.1M | 121,250.00%2.43M | --2.25M | --1.81M | --95K |
Total other finance cost | ---- | ---- | --179.93M | --60.85M | --0 | --0 | --119.09M | ---- | ---- | ---- |
Net investment income | -40.56%16.48M | -515.88%-23.71M | 153.03%31.07M | 90.79%-3.22M | -91.48%870K | 27.49%27.72M | -62.80%5.7M | 119.31%12.28M | -35M | 10.21M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -5.59%-431.71M | -408.87M | ||||||||
Income from associates and other participating interests | 1,508.57%48.65M | 44.56%5.85M | -39.86%-10.25M | 11.42%-5.32M | -3,911.03%-5.53M | -229.27%-3.45M | 1,054.25%4.05M | -220.28%-7.33M | -6M | 145K |
Special income (charges) | 0 | -57.38M | 1.86M | 0 | 0 | 0 | ||||
Less:Other special charges | --0 | --57.38M | ---1.86M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | -346.22%-815K | -42.41%26.63M | 422.60%136.15M | 209,504.88%85.94M | 1,272.18%3.65M | -87.36%331K | 99.90%46.23M | -32.91%26.05M | -94.91%41K | 266K |
Income before tax | 25.51%-373.31M | -53.24%-647.35M | 1.95%-2.53B | 17.92%-1.09B | -17.25%-520.67M | -11.36%-501.13M | -16.45%-422.44M | -111.34%-2.58B | -89.92%-1.33B | -444.05M |
Income tax | -313.08%-19.8M | 222.45%9.64M | 15.42%11.65M | 78.78%-2.34M | -62.09%1.71M | 10.74%9.29M | -63.62%2.99M | 164.42%10.09M | -966.27%-11.02M | 4.51M |
Net income | 30.74%-353.51M | -54.43%-656.99M | 1.88%-2.54B | 17.41%-1.09B | -16.46%-522.38M | -11.35%-510.42M | -14.68%-425.43M | -111.50%-2.59B | -88.00%-1.32B | -448.56M |
Net income continuous operations | 30.74%-353.51M | -54.43%-656.99M | 1.88%-2.54B | 17.41%-1.09B | -16.46%-522.38M | -11.35%-510.42M | -14.68%-425.43M | -111.50%-2.59B | -88.00%-1.32B | ---448.56M |
Noncontrolling interests | 0.00%-70K | -5.88%-72K | 7.53%-1.25M | 8.32%-1.05M | 1.45%-68K | -1.45%-70K | 9.33%-68K | -560.98%-1.36M | -1.14M | -69K |
Net income attributable to the company | 30.75%-353.44M | -54.44%-656.92M | 1.88%-2.54B | 17.42%-1.09B | -16.46%-522.31M | -11.35%-510.35M | -14.68%-425.36M | -111.43%-2.59B | -87.86%-1.31B | -448.49M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 30.75%-353.44M | -54.44%-656.92M | 1.88%-2.54B | 17.42%-1.09B | -16.46%-522.31M | -11.35%-510.35M | -14.68%-425.36M | -111.43%-2.59B | -87.86%-1.31B | -448.49M |
Gross dividend payment | ||||||||||
Basic earnings per share | 40.92%-23.56 | -33.35%-45.06 | 6.06%-197.05 | 22.28%-82.6 | -12.53%-40.78 | -7.38%-39.88 | -12.22%-33.79 | -101.82%-209.77 | -64.98%-106.28 | -36.24 |
Diluted earnings per share | 40.61%-23.6867 | -33.35%-45.06 | 6.06%-197.05 | 22.28%-82.6 | -12.53%-40.78 | -7.38%-39.88 | -12.22%-33.79 | -101.82%-209.77 | -64.98%-106.28 | -36.24 |
Dividend per share | ||||||||||
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |